全球数位诊断市场

到 2030 年，全球数位诊断市场规模将达到 31 亿美元

全球数位诊断市场规模预计在2024年达到12亿美元，预计2024年至2030年期间的复合年增长率为18.0%，到2030年将达到31亿美元。硬体组件是本报告分析的细分市场之一，预计其复合年增长率将达到17.5%，到分析期结束时规模将达到18亿美元。软体组件细分市场在分析期间内的复合年增长率预计为19.3%。

美国市场预计将达到 3.156 亿美元，而中国市场预计将以 23.6% 的复合年增长率成长

美国数位诊断市场规模预计在2024年达到3.156亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到6.931亿美元，在2024-2030年的分析期间内，复合年增长率为23.6%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个国家的复合年增长率分别为13.4%和16.2%。在欧洲，预计德国的复合年增长率约为14.3%。

全球数位诊断市场—主要趋势与驱动因素摘要

数位诊断将如何改变临床测试和监测？

数位诊断将医疗检测技术与数位平台结合，以改善疾病检测、患者监测和决策。数位诊断透过互联设备和软体实现快速、分散的检测，使医疗专业人员能够远端分析结果并即时共用见解。应用范围涵盖慢性病监测、传染病筛检、基因检测和远端病理。

透过数位系统获得的诊断数据会自动储存、分析，并通常整合到电子健康记录中，从而提高一致性并减少诊断错误。家用检测套组、基于智慧型手机的检测和穿戴式健康监测仪为患者提供即时回馈，并减少对医院基础设施的依赖。这些解决方案也有助于农村地区的医疗保健服务和疫情应对规划。

哪些技术正在提升数位诊断的能力？

生物感测器设计、微流体和微型化技术的进步，使得可携式诊断设备达到实验室级的精确度。透过蓝牙、Wi-Fi和云端系统实现的连接，实现了设备和医疗平台之间的持续资料传输。人工智慧演算法被用于放射学、病理学和皮肤病学的模式识别，从而提高了诊断速度和准确性。

分子诊断技术正在不断发展，并与数位PCR系统集成，从而提高对低水平生物标誌物的灵敏度。机器学习也正应用于解读基因组和蛋白质体数据，以实现个人化疾病分析。资料安全和加密框架确保了患者资料在各个平台的安全储存和共用。总而言之，这些技术有助于实现更早的检测、更快的结果取得和更完善的治疗途径。

数位诊断工具的采用在哪里加速？

医院和诊断实验室正在采用数位化解决方案来简化工作流程并管理更大的检测量。初级保健诊所正在使用快速诊断工具来缩短诊断时间并改善患者分诊。糖尿病、心血管疾病和呼吸系统疾病的家用诊断套件在老龄化社会和行动不便的患者中越来越受欢迎。

製药公司和临床试验营运商正在整合数位诊断技术，以实现远端患者监护和即时数据收集。公共卫生部门正在疾病爆发期间部署行动诊断单元和数位监测工具。在资源匮乏的地区，数位诊断平台可在社区健康中心和偏远村庄提供基本检测，从而提高可及性和公平性。

哪些因素推动了数位诊断市场的成长？

数位诊断市场的成长受到与医疗保健服务模式、技术进步和人口结构相关的多种因素的推动。对慢性病和感染疾病的早期准确诊断的需求日益增长，推动了携带式和联网检测系统的普及。向分散式护理和远端健康监测的转变，为家用和行动诊断工具创造了强劲的市场。

医疗记录的数位化和互通性正在推动诊断数据融入患者照护平台。感测器精度、设备便携性与人工智慧主导分析的持续创新，持续提升诊断的可靠性。支持性报销政策和政府对数位医疗基础设施的投资，正在促进更广泛的医疗服务可近性。随着医疗保健系统向基于价值的医疗服务迈进，数位诊断在效率、病人参与和临床场景的疗效追踪方面均取得了显着的提升。

部分

组件（硬体组件、软体组件、服务组件）；诊断类型（心臟病学诊断、肿瘤学诊断、神经病学诊断、放射学诊断、病理学诊断、其他诊断类型）；最终用户（医院/诊所最终用户、临床实验室最终用户、其他最终用户）

受访公司范例

• Aidoc
• AliveCor Inc.
• Arterys Inc.
• Babylon Health
• Biofourmis
• Butterfly Network, Inc.
• Canon Medical Systems Corp.
• Digital Diagnostics Inc.
• GE HealthCare Technologies Inc.
• HeartFlow, Inc.
• iCAD Inc.
• Infermedica
• Lunit Inc.
• Medtronic plc
• Nanox Imaging Ltd.
• PathAI
• Philips Healthcare
• Qure.ai
• Siemens Healthineers AG
• Viz.ai

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Digital Diagnostics Market to Reach US$3.1 Billion by 2030

The global market for Digital Diagnostics estimated at US$1.2 Billion in the year 2024, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 18.0% over the analysis period 2024-2030. Hardware Component, one of the segments analyzed in the report, is expected to record a 17.5% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Software Component segment is estimated at 19.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$315.6 Million While China is Forecast to Grow at 23.6% CAGR

The Digital Diagnostics market in the U.S. is estimated at US$315.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$693.1 Million by the year 2030 trailing a CAGR of 23.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.4% and 16.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.3% CAGR.

Global Digital Diagnostics Market - Key Trends & Drivers Summarized

How Are Digital Diagnostics Transforming Clinical Testing and Monitoring?

Digital diagnostics combines medical testing technologies with digital platforms to improve disease detection, patient monitoring, and decision-making. It enables rapid, decentralized testing through connected devices and software, allowing healthcare professionals to analyze results remotely and share insights in real time. Applications range from chronic disease monitoring and infectious disease screening to genetic testing and telepathology.

Diagnostic data captured through digital systems is automatically stored, analyzed, and often integrated into electronic medical records. This improves consistency and reduces diagnostic errors. At-home testing kits, smartphone-based assays, and wearable health monitors provide patients with real-time feedback and reduce dependence on hospital infrastructure. These solutions are also instrumental in rural healthcare delivery and pandemic response planning.

Which Technologies Are Advancing Digital Diagnostics Capabilities?

Advances in biosensor design, microfluidics, and miniaturization have enabled portable diagnostic devices that deliver lab-grade accuracy. Connectivity through Bluetooth, Wi-Fi, and cloud systems allows continuous data transmission between devices and healthcare platforms. AI algorithms are used for pattern recognition in radiology, pathology, and dermatology, improving diagnostic speed and precision.

Molecular diagnostics is evolving through integration with digital PCR systems, enhancing sensitivity for low-concentration biomarkers. Machine learning is also applied to interpret genomic and proteomic data for personalized disease profiling. Data security and encryption frameworks ensure safe storage and sharing of patient data across platforms. These technologies collectively support a shift toward earlier detection, faster results, and improved care pathways.

Where Is the Adoption of Digital Diagnostic Tools Accelerating?

Hospitals and diagnostic laboratories are implementing digital solutions to streamline workflows and manage higher testing volumes. Primary care clinics use rapid diagnostic tools to reduce time to diagnosis and improve patient triage. In-home diagnostic kits for diabetes, cardiovascular conditions, and respiratory illnesses are gaining acceptance among aging populations and patients with mobility constraints.

Pharmaceutical companies and clinical trial operators are integrating digital diagnostics to enable remote patient monitoring and real-time data capture. Public health authorities deploy mobile diagnostic units and digital surveillance tools during disease outbreaks. In low-resource settings, digital diagnostic platforms enable basic testing in community health centers and remote villages, improving access and equity.

What Factors Are Driving Growth in the Digital Diagnostics Market?

Growth in the digital diagnostics market is driven by several factors related to healthcare delivery models, technology advancements, and population health trends. Rising demand for early, accurate diagnosis of chronic and infectious diseases has increased deployment of portable and connected testing systems. Shift toward decentralized care and remote health monitoring has created a strong market for home-based and mobile diagnostic tools.

Digitalization of healthcare records and interoperability mandates have supported integration of diagnostic data into patient care platforms. Ongoing innovation in sensor accuracy, device portability, and AI-driven analytics continues to improve diagnostic reliability. Supportive reimbursement policies and government investments in digital health infrastructure are facilitating broader access. As healthcare systems move toward value-based care, digital diagnostics offer measurable improvements in efficiency, patient engagement, and outcome tracking across varied clinical settings.

SCOPE OF STUDY:

The report analyzes the Digital Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Hardware Component, Software Component, Services Component); Diagnosis Type (Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis, Other Diagnosis Types); End-User (Hospitals & Clinics End-User, Clinical Laboratories End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Aidoc
• AliveCor Inc.
• Arterys Inc.
• Babylon Health
• Biofourmis
• Butterfly Network, Inc.
• Canon Medical Systems Corp.
• Digital Diagnostics Inc.
• GE HealthCare Technologies Inc.
• HeartFlow, Inc.
• iCAD Inc.
• Infermedica
• Lunit Inc.
• Medtronic plc
• Nanox Imaging Ltd.
• PathAI
• Philips Healthcare
• Qure.ai
• Siemens Healthineers AG
• Viz.ai

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Digital Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Focus on Remote and At-Home Testing Accelerates Growth of Digital Diagnostic Platforms
  • Integration of Wearables and Mobile Health Tools Expands Real-Time Diagnostic Capabilities
  • AI-Powered Image Analysis Enhances Accuracy and Speed of Diagnostic Decision-Making
  • Growing Adoption of Telehealth Services Drives Demand for Integrated Digital Diagnostic Solutions
  • Rising Demand for Chronic Disease Monitoring Sustains Innovation in Connected Diagnostic Devices
  • Surge in Demand for Early Disease Detection Throws Spotlight on Non-Invasive Digital Tools
  • Expansion of Digital Pathology Platforms Spurs Cloud-Based Diagnostic Data Management
  • Growth in Point-of-Care Testing Environments Strengthens Case for Portable Diagnostic Devices
  • Digital Integration Across Hospital Systems Drives Seamless Diagnostic Data Interoperability
  • Rising Consumer Interest in Preventive Health Drives Uptake of At-Home Diagnostic Kits
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Digital Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Digital Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Digital Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Digital Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Hardware Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Software Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Services Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hospitals & Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Hospitals & Clinics End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Clinical Laboratories End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Clinical Laboratories End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Clinical Laboratories End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Cardiology Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Cardiology Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Cardiology Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Oncology Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Oncology Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Oncology Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Neurology Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Neurology Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Neurology Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Radiology Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Radiology Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Radiology Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Pathology Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Pathology Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Pathology Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Diagnosis Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Diagnosis Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Other Diagnosis Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• JAPAN
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• CHINA
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: China 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: China 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: China 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• EUROPE
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Digital Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Digital Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Digital Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• FRANCE
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: France 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: France 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: France 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• GERMANY
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: Germany 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: Italy 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: UK 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: UK 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: UK 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Spain 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Russia 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Digital Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Digital Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Digital Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: Australia 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• INDIA
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: India 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: India 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: India 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: South Korea 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Digital Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Digital Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Digital Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Latin America 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Argentina 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Brazil 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: Mexico 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Digital Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Digital Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Digital Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Middle East 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Iran 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: Israel 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: UAE 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• AFRICA
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 313: Africa 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030

IV. COMPETITION